Tectonic Therapeutic | AVRO - Cash And Equivalent


Tectonic Therapeutic reported $236.89M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Akebia Therapeutics USD 162.64M 22.2M Mar/2026
Alnylam Pharmaceuticals USD 1.71B 53.53M Mar/2026
Celltrion KRW 49.87B 20.22B Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Gilead Sciences USD 7.56B 234M Dec/2025
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Karyopharm Therapeutics USD 60.54M 22.87M Dec/2025
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
MacroGenics USD 66.52M 9.3M Mar/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organigram Holdings CAD 7.58M 20.62M Dec/2025
Pfizer USD 1.7B 561M Mar/2026
Pharma Mar EUR 48.86M 31.05M Mar/2026
Qiagen NV USD 839M 516.58M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sarepta Therapeutics USD 464.45M 336.83M Mar/2026
Sartorius EUR 573.8M 32.4M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Takeda JPY 654.94B 26.55B Dec/2025
Tilray USD 264.83M 43.16M Jun/2025
Zealand Pharma A/S 4.58B 1.4B Dec/2025
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026